BerandaASRT • NASDAQ
add
Assertio Holdings Inc
Tutup sebelumnya
$0,84
Rentang hari
$0,80 - $0,84
Rentang tahun
$0,74 - $1,80
Kapitalisasi pasar
76,43Â jt USD
Volume Rata-Rata
809,48Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 29,20Â jt | -18,03% |
Biaya operasional | 24,40Â jt | -18,13% |
Laba bersih | -2,92Â jt | 98,96% |
Margin laba bersih | -10,00 | 98,73% |
Penghasilan per saham | 0,03 | 200,00% |
EBITDA | 3,96Â jt | -56,54% |
Tarif pajak efektif | -1,53% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 88,58Â jt | 15,21% |
Total aset | 276,00Â jt | -27,37% |
Total liabilitas | 145,48Â jt | -22,27% |
Total ekuitas | 130,52 jt | — |
Saham yang beredar | 95,48 jt | — |
Harga terhadap nilai buku | 0,61 | — |
Tingkat pengembalian aset | -2,47% | — |
Tingkat pengembalian modal | -4,00% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -2,92Â jt | 98,96% |
Kas dari operasi | -35,00Â rb | -101,36% |
Kas dari investasi | -6,71Â jt | -261,90% |
Kas dari pembiayaan | -10,00Â rb | 0,00% |
Perubahan kas bersih | -6,75Â jt | -200,61% |
Arus kas bebas | 900,88Â rb | 99,64% |
Tentang
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration. On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Wikipedia
Didirikan
1995
Kantor pusat
Situs
Karyawan
53
